Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
NCT00443716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2010-01-15
Summary
To evaluate the effect of estrogen treatment on adipocytic and osteoblastic parameters by histomorphometrically measuring adipocyte volume (AV/TV) and adipocyte numbers in goldner's stained iliac crest bone biopsy specimens collected from subjects recruited in the study (IRB number 21B85). The adipocytic parameters will be then correlated with osteoblastic parameters obtained previously during the course of the initai study involving the effect of transdermal estrogen on bone turnover in postmenopausal osteoporotic women.
Conditions
- Osteoporosis
- Postmenopausal
Interventions
- DRUG
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
B. Lawrence Riggs, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1985-04-30
- Primary Completion
- 1989-04-30
- Completion
- 1989-04-30
Countries
- United States
Study Locations
More Related Trials
-
Osteoclast Inhibition and Bone Formation
NCT02554695 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Rhythmic Estradiol and Bone Health
NCT05903820 ·Status: COMPLETED ·Phase: PHASE4
-
Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass
NCT00489424 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Investigational Drug in Osteoporosis (MK-0217-908)
NCT00092053 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)
NCT01011725 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Effects of Raloxifene Treatment on Bone Quality
NCT00532428 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
NCT00431444 ·Status: COMPLETED ·Phase: PHASE4
-
A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women
NCT00902356 ·Status: COMPLETED ·Phase: PHASE1
-
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
NCT04026256 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women
NCT00941473 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Arzoxifene on Bone Mass and the Uterus
NCT00085956 ·Status: COMPLETED ·Phase: PHASE3
-
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
NCT00887965 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
NCT00837746 ·Status: COMPLETED
-
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
NCT00004406 ·Status: COMPLETED ·Phase: NA
-
Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy
NCT00165204 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
NCT00436917 ·Status: COMPLETED ·Phase: NA
-
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
NCT00354302 ·Status: COMPLETED ·Phase: PHASE3
-
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
NCT00089661 ·Status: COMPLETED ·Phase: PHASE3
-
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
NCT00043186 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
NCT00708175 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY2541546 in Women With Low Bone Mineral Density
NCT01144377 ·Status: COMPLETED ·Phase: PHASE2
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
NCT00049452 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors
NCT02616744 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea
NCT07015476 ·Status: RECRUITING